RVMD Revolution Medicines, Inc.
Price Chart
Executive Summary
Director Margaret A. Horn files Form 144 notice of intent to sell 10,000 shares (~$1.44M based on stated value). This is a relatively modest sale relative to the $30.7B market cap, representing ~0.00003% of shares outstanding. The shares are being sold to cover option exercise costs, a routine insider transaction pattern.
Actionable Insight
The filing itself is routine and not directly actionable. Monitor for the executed Form 4 to confirm the sale actually occurred — the ~$1.44M amount is small relative to market cap and likely tax-motivated option exercise covering. No bearish read-through for RVMD from this isolated insider filing.
Key Facts
- Director Margaret A. Horn filed Form 144 on 2026-06-11
- Proposed sale of 10,000 shares with approximate value of $1,441,900
- Shares to be sold through Morgan Stanley Smith Barney LLC
- Sale is to cover costs of exercising stock options (cash exercise)
- Horn not a named executive officer — holds board director role
Financial Impact
~$1.44M proposed sale value; director ownership stake undisclosed but likely moderate at ~$30.7B market cap
Risk Factors
- Insider may be incrementally reducing exposure ahead of any near-term clinical data readout
- Form 144 is intent-to-sell only; sale may not execute if conditions change
Market Snapshot
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001950047-26-005947 |
| Document: 0001950047-26-005947-index.html | 0001950047-26-005947 |
| Document: 0001950047-26-005947.txt | 0001950047-26-005947 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 11, 2026
1d ago
|
144
| $149.21 awaiting T+5 | awaiting T+5 | — | $153.87 (+3.12%) |
|
May 31, 2026
13d ago
|
Press Release
| $163.68 $149.23 | ▼ −8.83% | ▼ −6.08% | $153.87 (−5.99%) |
|
May 6, 2026
5w ago
|
Press Release
| $142.51 $149.94 | ▲ +5.21% | ▲ +3.71% | $153.87 (+7.97%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $141.50 $140.80 | ▼ −0.49% | ▼ −0.55% | $153.87 (+8.74%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $141.50 $140.80 | ▼ −0.49% | ▼ −0.55% | $153.87 (+8.74%) |
|
Apr 21, 2026
7w ago
|
Press Release
| $148.90 $144.83 | ▼ −2.73% | ▼ −3.82% | $153.87 (+3.34%) |
|
Apr 19, 2026
7w ago
|
Press Release
| $146.23 $131.67 | ▼ −9.96% | ▼ −10.87% | $153.87 (+5.22%) |
|
Apr 17, 2026
8w ago
|
Press Release
| $146.23 $131.67 | ▲ +9.96% | ▲ +10.87% | $153.87 (−5.22%) |
|
Apr 15, 2026
8w ago
|
Press Release
| $152.54 $141.50 | ▲ +7.24% | ▲ +8.88% | $153.87 (−0.87%) |
|
Apr 13, 2026
8w ago
|
Press Release
| $147.01 $148.90 | ▼ −1.29% | ▲ +0.11% | $153.87 (−4.67%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access